HUTCHMED (LON:HCM) Stock Price Crosses Above 50-Day Moving Average – Here’s Why

HUTCHMED (China) Limited (LON:HCM)’s stock price passed above its 50 day moving average during trading on Monday . The stock has a 50 day moving average of GBX 212.90 and traded as high as GBX 237.54. HUTCHMED shares last traded at GBX 224.10, with a volume of 51,652 shares changing hands.

HUTCHMED Price Performance

The firm has a market capitalization of £1.98 billion, a P/E ratio of 4.35 and a beta of 0.76. The company has a current ratio of 2.81, a quick ratio of 2.97 and a debt-to-equity ratio of 11.97. The firm has a 50 day moving average price of GBX 212.90 and a 200-day moving average price of GBX 229.28.

About HUTCHMED

We are among the first global-focused novel drug discovery companies in China. Over the past two decades, we have established a fully integrated R&D platform with world-class discovery and development capabilities. Since inception, we have focused on bringing cancer drug candidates from in-house discovery to patients around the world, with our first three oncology medicines now approved marketed in China, the first of which is also marketed in the U.S.

We have also developed a profitable commercial platform with deep pan-China market access, which manufactures, markets and distributes our novel oncology products, as well as prescription drugs and consumer health products in China.

HUTCHMED is listed on the Nasdaq Global Select Market, the Stock Exchange of Hong Kong Limited and the London Stock Exchange’s AIM market (Nasdaq/AIM:HCM; HKEX:13).